Dose Optimization of Targeted Therapies for Oncologic Indications

Cancers (Basel) · 2024 · PMC11202153

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

In some instances, concerns with dose may be significant enough that PMRs or PMCs will not be sufficient recourse to address them.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.